Consolidated statement of cash flows [1]
| Note | 2014 | 2013 | |
|---|---|---|---|
| Net cash flows from operating activities | |||
| Profit before income tax | 4,034,563 | 4,044,464 | |
| Adjustments: | (2,010,153) | (5,181,159) | |
| Amortisation and depreciation | 747,164 | 579,240 | |
| (Gains) losses from investing activities | 42 [2] | (17,629) | (432,805) |
| Interest and dividends | 42 [2] | (70,072) | (526,650) |
| Change in amounts due from banks | 42 [2] | 516,391 | 932,282 |
| Change in trading assets and financial assets designated upon initial recognition at fair value through profit and loss | 42 [2] | 3,636,624 | (2,777,360) |
| Change in derivative financial instruments (asset) | 42 [2] | (2,465,578) | 859,701 |
| Change in loans and advances to customers | 42 [2] | (6,368,592) | (6,014,711) |
| Change in other assets, inventories and non-current assets held for sale | 42 [2] | 22,298 | (123,665) |
| Change in amounts due to banks | 42 [2] | (10,148,916) | (254,374) |
| Change in derivative financial instruments (liability) | 42 [2] | 2,205,844 | (635,887) |
| Change in amounts due to customers | 42 [2] | 9,077,138 | 4,704,388 |
| Change in liabilities classified as held for sale | 32,084 | 2,880 | |
| Change in debt securities in issue | 42 [2] | 797,462 | 542,532 |
| Change in provisions and impairment allowances | 42 [2] | 1,298,353 | (598,898) |
| Change in other liabilities, liabilities due to insurance operations and | |||
| subordinated liabilities | 42 [2] | 315,877 | 719,951 |
| Income tax paid | (842,623) | (1,033,741) | |
| Other adjustments | 42 [2] | (745,978) | (1,124,042) |
| Net cash generated from/used in operating activities | 2,024,410 | (1,136,695) | |
| Net cash flows from investing activities | |||
| Inflows from investing activities | 44,158,212 | 45,064,980 | |
| Proceeds from sale of a subsidiary, net of cash disposed | - | 383,561 | |
| Proceeds from sale of non-current assets held for sale | - | 25,450 | |
| Proceeds from sale and interest on investment securities | 44,056,862 | 44,610,734 | |
| Proceeds from sale of intangible assets and tangible fixed assets | 73,451 | 43,347 | |
| Other investing inflows (dividends) | 27,899 | 1,888 | |
| Outflows from investing activities | (51,861,334) | (46,096,798) | |
| Purchase of subsidiaries, net of cash acquired | (1,797,972) | (39) | |
| Purchase of investment securities | (49,249,230) | (45,040,357) | |
| Purchase of intangible assets and tangible fixed assets | (814,132) | (1,056,402) | |
| Net cash used in investing activities | (7,703,122) | (1,031,818) | |
| Net cash flows from financing activities | |||
| Proceeds from debt securities in issue | 3,569,624 | 2,119,934 | |
| Redemption of debt securities in issue | (1,612,922) | (2,032,020) | |
| Dividends paid | (937,500) | (2,250,000) | |
| Repayment of interest from issued debt securities and subordinated loans | (475,673) | (478,531) | |
| Long-term borrowings | 15,287,591 | 1,974,081 | |
| Repayment of long-term borrowings | (4,782,292) | (775,844) | |
| Net cash generated from/used in financing activities | 11,048,828 | (1,442,380) | |
| Net cash flows | 5,370,116 | (3,610,893) | |
| of which currency translation differences on cash and cash equivalents | 125,680 | (16,722) | |
| Cash and cash equivalents at the beginning of the period | 8,884,739 | 12,495,632 | |
| Cash and cash equivalents at the end of the period | 42 [2] | 14,254,855 | 8,884,739 |
| of which restricted | 16 [3] | 11,440 | 32,078 |